Diabetes

Clinical evidence synopsis published for T2DM

(HealthDay)—Adding a sulfonylurea or metformin to insulin is associated with approximately a 1 percent reduction in hemoglobin A1c (HbA1c), and addition of a sulfonylurea (but not metformin) is associated with more hypoglycemic ...

Diabetes

Peer coaching model beneficial for patients with diabetes

(HealthDay)—Health coaching by peers is associated with a significant reduction in hemoglobin A1c (HbA1c) levels among patients treated in public health clinics, according to research published in the March/April issue ...

Diabetes

Achievement of targets in T2DM varies by season

(HealthDay)—There is seasonal variation in achievement of the guideline targets for hemoglobin A1c (HbA1c), blood pressure (BP), and low-density lipoprotein (LDL) cholesterol among persons with type 2 diabetes mellitus ...

Health

Short duration between dinner, bed has no effect on HbA1c

(HealthDay)—Ensuring a short duration between dinner and bedtime has no effect on hemoglobin A1c (HbA1c) levels in middle-aged and older Japanese adults, according to a study published online Jan. 22 in BMJ Nutrition, Prevention ...

Medications

Medication nonadherence common in patients with T2DM

(HealthDay)—Routine urine samples can be used to test for medication adherence in patients with type 2 diabetes, according to a study published in the June issue of Diabetes Care.

Psychology & Psychiatry

Cardiometabolic risk factors in early schizophrenia ID'd

(HealthDay)—Factors showing increased risk for cardiometabolic disorders are present in patients with first-episode schizophrenia spectrum disorders (FES), according to research published online on Oct. 8 in JAMA Psychiatry.

Cardiology

Risk conferred by T2D modified by HbA1c in heart failure

(HealthDay)—For patients with heart failure, the risks conferred by type 2 diabetes (T2D) can be stratified by glycemic control and drug treatments, according to a study published online Oct. 11 in JACC: Heart Failure.

page 13 from 16